Therefore, it is conceivable that the contribution of Tregs to T1D pathology might be influenced by enhanced IL-27 signaling in T1D patients; however, the exact range of effects is still unclear and warrants further investigation. This evidence concerns the gene IL27 and type 1 diabetes mellitus.